1Kracmar J, Kracmarova J, Stejskal Z. UV spectrophotometry in drug analysis. Part 33 : New drugs carrying benzene, pyridine, quinoline, and phenanthrene chromophores. Part 6: Effect of substitution and solvents. Phatmaz/e, 1987,42( 1 ) : 18
2Kxacmar J, Kxacmarova J, Galova E. Ultraviolet spectrophotometry in drug control. ⅩⅩⅫ. New pharmaceuticals containing benzene, pyridine, quinoline and phenanthrene chromophores. 5. Effect of substitution and solvents. Cesk Farm, 1986,35 ( 7 ) : 303
3Neill EAM. A note on the determination of atracurium and its metabolites. Methodol Surv Biochem Anal, 1983,12 ( Drug Metab Isol Determ) :243
4Kerskes CHM, Lusthof KJ, Zweipfenning PGM, et al. The detection and identification of quaternary nitrogen muscle relaxants in biological fluids and tissues by ion - tap LC - ESI - MS. J Anal Toxicol, 2002,26(1) :29
5Farenc C, Audran M, Lefrant JY, et al. High - performance liquid chromatographic method for the determination of atracurium and laudanosine in human plasma. Application to pharmacokinetics. J Chromatogr B. Biomed Sci Appl , 1999,724( 1 ) :117
6Simmonds RJ. Determination of atracurium, laudanosine and related compounds in plasma by high - performance liquid chromatography. J Chromatogr, 1985,343 (2) :431
7Aleksic M, Odovic J, Milojkovic - Opsenica DM, et al. Salting - out thin - layer chromatography of several myorelaxants. J Plan Chromatogr- - Mod TLC,2003 ,16( 2 ) :144
8Caldwell R, Challenger H. A capillary column gas -chromatographic method for the identification of drugs of abuse in urine samples. Ann Clin Biochem, 1989,26 (5) :430
9Nielsen PF, Roepstorff P. Determination of atracurium in human plasma by derivative spectrophotometry. Biomed Environ Mass Spectrom,1988 ,17 ( 2 ) :137
